IP portfolio reflects Autonomix’s neural sensing leadership in multi-billion-dollar denervation market
Technical highlights on newly issued patent include real-time nerve monitoring and diagnostic evaluation
Read more at globenewswire.comAutonomix Medical Strengthens Global Intellectual Property Position with New Neural Sensing Patent Grant
Barchart·07/13/2026 06:30:00
語音播報
This article contains syndicated content. We have not reviewed, approved, or endorsed the content, and may receive compensation for placement of the content on this site. For more information please view the Barchart Disclosure Policy here.